43
1
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T10696 | CB2 modulator 1 | Cannabinoid Receptor | |
CB2 modulator 1 is a potent CB2 modulator. It can be used for the research for immune disorders, osteoporosis, inflammation, renal ischemia. | |||
T12306 | OMDM-5 | Cannabinoid Receptor , Endogenous Metabolite , TRP/TRPV Channel | |
OMDM-5 is a selective anandamide cellular uptake (ACU)inhibitor(Ki of 4.8 μM). | |||
T12302 | OMDM-1 | (Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide | Endogenous Metabolite |
OMDM-1 ((Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide) is a selective and metabolically stable anandamide cellular uptake (ACU)inhibitor with a Ki of 2.4 μM. | |||
T22009 | CB2 receptor agonist 2 | ZINC72105556,4-Quinolone-3-Carboxamide Furan CB2 Agonist | Cannabinoid Receptor |
CB2 receptor agonist 2 (ZINC72105556) is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor, Ki = 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2. | |||
T6527 | GW842166X | Cannabinoid Receptor | |
GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2. | |||
T6755 | AM1241 | Cannabinoid Receptor | |
AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor. | |||
T14302 | Olorinab | APD 371 | Cannabinoid Receptor |
Olorinab (APD 371) (APD 371) is a highly potent, selective and fully efficacious cannabinoid receptor type 2 (CB2) agonist. With an EC50 of 6.2 nM for hCB2. | |||
T7375 | A-836339 | Cannabinoid Receptor | |
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 receptor (Ki = 270 nM). It displays analgesic, anti-inflammatory... | |||
T7316 | LY2828360 | Cannabinoid Receptor | |
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100,000 nM, respectively). | |||
T41231 | GP 1a | Cannabinoid Receptor , PERK , Arrestin | |
GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and incr... | |||
T37075 | CB2R PAM | Ec2la | Cannabinoid Receptor |
CB2R PAM is an orally active cannabinoid type 2 receptor (CB2Rs) positive mutational modulator that enhances CP 55940 and 2-Arachidonylglycerol-stimulated [35S]GTPγS binding to CB2 receptors, but has no effect in the abs... | |||
T3530 | Otenabant | CP-945598 | Cannabinoid Receptor |
Otenabant (CP-945598) has been investigated for the treatment of Obesity. | |||
T10697 | CB2R-IN-1 | Others | |
CB2R-IN-1 is a potent inverse agonist of the cannabinoid CB2 receptor (Ki: 0.9 nM). | |||
T32336 | JWH-149 | ||
JWH 149, a synthetic cannabinoid (CB), can potently bind both the central CB1 receptor (Ki = 5.0 nM) and the peripheral CB2 receptor (Ki = 0.73 nM). | |||
T25874 | NMP-7 | NMP7,NMP 7 | |
NMP-7 is a non-selective CB1 and CB2 cannabinoid receptor agonist that works by blocking T-type calcium channels. | |||
T24218 | JTE 7-31 | ||
JTE 7-31 is a selective agonist of the cannabinoid receptor. It is a reasonably highly selective CB2 agonist (Ki: 0.088 nM at CB2 vs 11 nM at CB1). | |||
T32341 | JWH-251 | ||
JWH 251, a cannabimimetic indole, has a high affinity tothe central cannabinoid (CB1) receptor (Ki = 29 nM) and a comparatively modest affinity for the peripheral cannabinoid (CB2) receptor (Ki = 146 nM). JWH 251 can st... | |||
T17027 | Tedalinab | GRC-10693 | Cannabinoid Receptor |
Tedalinab is an effective and selective cannabinoid receptor 2 agonist. Tedalinab has the potential for neuropathic pain and osteoarthritis treatment. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. | |||
T24939 | Virodhamine trifluoroacetate | Virodhamine-trifluoroacetate,Virodhamine trifluoroacetate salt | |
Virodhamine trifluoroacetate is an antagonist of endogenous cannabinoid receptor mixed that acts by being a full agonist at GPR55 and CB2 and partial antagonist at CB1. | |||
T14504 | BAY 38-7271 | Cannabinoid Receptor | |
BAY 38-7271 has strong neuroprotective properties.[1] BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist. With Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 recept... | |||
T29933 | AM-1714 | UNII-E3OY6PCU04,AM1714 | |
AM-1714 is a reasonable selective agonist for the peripheral cannabinoid receptor CB2. In animal studies, it has been shown to have analgesic and anti-abnormal pain effects. | |||
T32582 | LASSBio-881 | LASSBio881,LASSBio 881 | |
LASSBio-881 is a non-selective partial agonist of the CB1 and CB2 cannabinoid receptors, as well as an antagonist of the TRPV1 receptor. | |||
T32334 | JWH-098 | ||
JWH 098, a potent synthetic cannabinoid (CB), can activate the CB1 receptor with a Ki value of 4.5 nM and the CB2 receptor with a Ki value of 1.88 nM. Its effects in cells and animals are still on study. | |||
T32331 | JWH 072 | JWH072,JWH-072 | |
JWH 072 , known as synthetic cannabinoid (CB), displays a higher affinity to the peripheral CB2 receptor (Ki = 170 nM) than the central CB1 receptor (Ki = 1,050 nM). Its physiological and toxicological properties are sti... | |||
T38912 | Vicasinabin | ||
Vicasinabin, a potent agonist of cannabinoid receptor 2 (CB2), exhibits promising potential for researching chronic pain, atherosclerosis, regulation of bone mass, neuroinflammation, and related human diseases. | |||
T30903 | CHM-081 | CHM 081 | |
JWH 081, a cannabimimetic aminoalkylindole, has a high-affinity to the central cannabinoid (CB1) receptor (Ki =1.2 nM) and ten-fold reduced affinity to the peripheral cannabinoid (CB2) receptor (Ki = 12.4 nM). JWH 081-N-... | |||
T32338 | JWH-182 | JWH182 | |
JWH 182, a potent synthetic cannabinoid (CB) can activate the central CB1 receptor and the peripheral CB2 receptor with a Ki value of 0.65 nM and 1.1 nM, respectively. Its effects in cells and animals have not evaluated. | |||
T36566 | Amauromine | ||
Amauromine is a neutral antagonist of the cannabinoid (CB) receptor CB1 that is selective for CB1 (Ki = 178 nM; Kb = 66.6 nM) over CB2, with no activity at CB2 receptors at concentrations up to 10 μM. It is also an antag... | |||
T38049 | Glycerophospho-N-Palmitoyl Ethanolamine | ||
N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities. For example, arachidonoyl ethanolamide (AEA) is an endogenous neurotransmitter that evokes cellular responses by activating t... | |||
T38199 | (±)-WIN 55,212 (mesylate) | ||
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively.... | |||
T68247 | PSB-KD107 | ||
PSB-KD107 is an agonist of the Cannabinoid-Activated Orphan G‑Protein-Coupled Receptor GPR18. PSB-KD107 displayed significantly higher potency and efficacy than THC, determined in a GPR18-dependent β-arrestin recruitment... | |||
T38147 | (S)-AM1241 | (S)-AM1241 | |
(S)-AM1241 binds to cannabinoid (CB) receptors and is selective for the CB2 over the CB1 receptor (Kis = 658 and >10,000 nM, respectively, in a membrane assay using human receptors). (S)-1241 acts as an agonist at human,... | |||
T38030 | (R)-AM1241 | (R)-AM1241 | |
(R)-AM1241 binds to cannabinoid (CB) receptors and has greater than 100-fold selectivity for the CB2 over the CB1 receptor (Kis = 15 and 5,000 nM, respectively, in a membrane assay using human receptors). (R)-AM1241 acts... | |||
T21914 | (S)-SLV 319 | ||
Ibipinabant (SLV319) is a potent, selective, and orally active antagonist of the cannabinoid CB1 receptor, demonstrating a K i of 7.8 nM and exhibiting over 1000-fold selectivity for CB1 compared to CB2 (K i =7943 nM). I... | |||
T62132 | S-777469 | ||
S-777469 is a selective, orally active agonist of the cannabinoid type 2 receptor (CB2) (Ki: 36 nM). s-777469 significantly inhibited compound 48/80-induced scratching behaviour in mice in a dose-dependent manner. s-7774... | |||
T27809 | LEI-101 | ||
LEI-101 is a potent, selective, and orally bioavailable cannabinoid CB2 receptor agonist, with a pEC 50 of 8 for hCB2, and a pK i of less than 4 for hERG. LEI-101 is ~100-fold more potent in binding to CB2 receptors than... | |||
T38138 | ACEA | 2'-chloro-AEA,Arachidonoyl 2'-Chloroethylamide | |
Arachidonoyl 2-chloroethylamide (ACEA) is a potent and selective cannabinoid (CB) receptor 1 agonist with Ki values of 1.4 and >2,000 nM for CB1 and CB2 receptors, respectively. In whole animal experiments, ACEA induces ... | |||
T71963 | (−)-WIN 55,212-3 mesylate | ||
(−)-WIN 55,212-3 mesylate is an aminoalkylindole derivative which acts as a competitive neutral antagonist of the human cannabinoid CB2 receptor, blocking both the stimulating action of CP 55,940 and the inverse agonism ... | |||
T79577 | CB2 PET Radioligand 1 | Cannabinoid Receptor | |
CB2 PET Radioligand 1 (compound [18F]9) is a positron emission tomography (PET) radioligand with high affinity for the human cannabinoid receptor 2 (hCB2, Ki=7.7 nM). It is synthesized via Cu-mediated 18F-fluorination an... | |||
T23099 | O-2050 | Others | |
O-2050 is a high affinity cannabinoid CB 1 receptor antagonist with a K i of 2.5 nM. O-2050 inhibits cannabinoid CB 2 receptor with Ki of 0.2 nM. O-2050 decreased food intake in mice and caused locomotor stimulation in m... | |||
T69612 | PSB-KD477 | ||
PSB-KD477 is an Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18. PSB-KD477 displayed significantly higher potency and efficacy than THC, determined in a GPR18-dependent β-arrestin recruitment... | |||
T35408 | (±)10(11)-EDP Ethanolamide | ||
(±)10(11)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 0.43 and 22.5 nM for CB1 and CB2 receptors, respectively). It is produced though direct epoxygenation of docosah... | |||
T35468 | (±)19(20)-EDP Ethanolamide | ||
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). It is produced through direct epoxygenation of docosahexaenoyl et... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN2268 | Tetrahydromagnolol | Cannabinoid Receptor , GPR , GABA Receptor | |
Tetrahydromagnolol can activate cannabinoid (CB) receptors. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06623 | CB2/CNR2 Protein, Human, Recombinant | Human | HEK293 |
Genetic variants within the CNR2 gene encoding the cannabinoid receptor CB2 are associated with osteoporosis and low bone mineral density (BMD) in case-control studies. There is a possibility that genetic variants of the... |